Stock market anomaly: Shi Pharm Group (01093.HK) rose more than 3% as SYH2066 tablets received clinical trial approval in China.

According to the Wise Finance app, SinoPharm Group (01093.HK) rose by more than 3%, as of the time of publication, it rose by 2.32% to HK$10.58, with a trading volume of HK$5.26 billion.